Literature DB >> 7525011

Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's beta-amyloid protein precursor in the brain.

R Pluta1, E Kida, A S Lossinsky, A A Golabek, M J Mossakowski, H M Wisniewski.   

Abstract

The distribution of beta-amyloid protein precursor (APP) was investigated immunocytochemically in rats subjected to global cerebral ischemia (GCI) induced by cardiac arrest. Rats underwent 10 min of GCI with 3, 6, and 12 h and 2 and 7 days of survival. APP immunostaining was found extracellular and intracellularly. Multiple extracellular APP immunoreactive deposits around and close to the vessels appeared as soon as 3 h after GCI. Extracellular accumulation of APP occurred frequently in the hippocampus, cerebral and cerebellar cortex, basal ganglia and thalamus and rarely in the brain stem. These deposits were labelled with antibodies against the N-terminal, beta-amyloid peptide, and C-terminal domains of APP. Our data suggests that either proteolytically cleaved fragments of the full-length APP or the entire APP molecule accumulates extracellularly after GCI. This findings may not only implicate the participation of APP in postischemic tissue damage but also suggest the involvement of pathomechanisms operating in ischemia in Alzheimer's disease pathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525011     DOI: 10.1016/0006-8993(94)91081-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  Ribonuclease improves the state of hippocampal sections in the post-ischemic period.

Authors:  I E Kudryashov; I V Kudryashova; V V Raevskii
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

Review 2.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

Review 3.  Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Authors:  J Szczygielski; A Mautes; W I Steudel; P Falkai; T A Bayer; O Wirths
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  Is there a genetic basis for the deposition of beta-amyloid after fatal head injury?

Authors:  D I Graham; S M Gentleman; J A Nicoll; M C Royston; J E McKenzie; G W Roberts; R E Mrak; W S Griffin
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

5.  Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins.

Authors:  Francesca Ruberti; Christian Barbato; Carlo Cogoni
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 6.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

7.  Association of Induced Hyperhomocysteinemia with Alzheimer's Disease-Like Neurodegeneration in Rat Cortical Neurons After Global Ischemia-Reperfusion Injury.

Authors:  Maria Kovalska; Barbara Tothova; Libusa Kovalska; Zuzana Tatarkova; Dagmar Kalenska; Anna Tomascova; Marian Adamkov; Jan Lehotsky
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

8.  Ventricular fibrillation-induced cardiac arrest in the rat as a model of global cerebral ischemia.

Authors:  Kunjan R Dave; David Della-Morte; Isabel Saul; Ricardo Prado; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2013-10       Impact factor: 6.829

9.  Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Marzena U Amek
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

10.  Amyloid-beta disrupts calcium and redox homeostasis in brain endothelial cells.

Authors:  Ana Catarina R G Fonseca; Paula I Moreira; Catarina R Oliveira; Sandra M Cardoso; Paolo Pinton; Cláudia F Pereira
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.